503a pharmacy bpc 157 healthyaging #bpc157 #casapharmarx FDA is reviewing seven peptides

FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them Big decisions could be coming for peptide compounding. Over the next few days, the FDA's Pharmacy Compounding Advisory Committee will discuss several peptides, including BPC 157, and whether they should be considered for Heal or Harm: Body Protective Compound 157 in the Gray Zone Pharmacy Times

SKU: 91337259218 · From clintoncounty708.com